ST AIA-PACK C-PeptideII

C-peptide originates from pancreatic β-cell as a metabolically by-product in the synthesis of insulin from proinsulin. One molecule of C-peptide is formed as one molecule of insulin is formed, hence measuring the level of C-peptide can ascertain insulin secretion ability. It is possible to estimate the level of endogenous insulin secretion in diabetes patients on insulin therapy by measuring the level of C-peptide. Anti-insulin antibodies are commonly found in patients who have undergone insulin therapy. These circulating anti-insulin antibodies may interfere with certain immunoassays for insulin, making it difficult to use as a measure of residual β-cell activity. C-peptide measurement is therefore used as an alternative measurement index in this context. C-peptide measurement is also used as an additional means of evaluating glucose tolerance tests. 

Technical specifications

Refer to the product Instruction-For-Use (IFU) for complete details.